Cytoplasmic melanoma-associated antigen
β
Sandra R. Reynolds; Irene J. Vergilis; Michael Szarek; Soldano Ferrone; Jean-Cla
π
Article
π
2006
π
John Wiley and Sons
π
French
β 135 KB
## Abstract Simple, noninvasive methods are needed to follow effectiveness of new treatments in patients with melanoma. In our study, we examined cytoplasmic melanomaβassociated antigen (CYTβMAA) serum level in melanoma patients during immunotherapy. Sera of 117 patients were assayed for CYTβMAA by